Your browser doesn't support javascript.
loading
ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's disease.
Rascol, O; Blin, O; Thalamas, C; Descombes, S; Soubrouillard, C; Azulay, P; Fabre, N; Viallet, F; Lafnitzegger, K; Wright, S; Carter, J H; Nutt, J G.
Affiliation
  • Rascol O; Clinical Investigation Centre, Department of Pharmacology, INSERM U455, University Hospital, Toulouse, France.
Ann Neurol ; 45(6): 736-41, 1999 Jun.
Article in En | MEDLINE | ID: mdl-10360765
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Pyridines / Tetrahydronaphthalenes / Prodrugs Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Neurol Year: 1999 Document type: Article Affiliation country: Francia Country of publication: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Pyridines / Tetrahydronaphthalenes / Prodrugs Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Neurol Year: 1999 Document type: Article Affiliation country: Francia Country of publication: Estados Unidos